Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS

Dr Carmel Harrington joins eBioMedicine to discuss about their findings of a potential biomarker for sudden infant death syndrome.

Read the full article:
Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv